X4 Pharmaceuticals, Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
X4 Pharmaceuticals, Inc has filed 796 SEC EDGAR filings since 24 Sep 2010

SEC filing history

Showing 1-25 of 796 matching filings.

Per page
25
Current page
1
SCHEDULE 13G/A File 005-90199

SCHEDULE 13G/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-295597

EFFECT filing

Filing date
14 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 May 2026
Reporting date
12 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38295

144 filing

Filing date
12 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
12 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-295597

UPLOAD filing

Filing date
11 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-38295

ARS

Filing date
20 Mar 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38295

DEFA14A

Filing date
20 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38295

DEF 14A

Filing date
20 Mar 2026
Reporting date
20 Mar 2026
Next action
Verify source filing
SCHEDULE 13G/A File 005-90199

SCHEDULE 13G/A filing

Filing date
06 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-90199

SCHEDULE 13G/A filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-90199

SCHEDULE 13G/A filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-90199

SCHEDULE 13G/A filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90199

SCHEDULE 13G filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-90199

SCHEDULE 13G/A filing

Filing date
13 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90199

SCHEDULE 13G filing

Filing date
12 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-90199

SCHEDULE 13G/A filing

Filing date
05 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-90199

SCHEDULE 13G/A filing

Filing date
15 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jan 2026
Reporting date
01 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .